The UDP-Glucuronosyltransferase 2B7 Isozyme Is Responsible for Gemfibrozil Glucuronidation in the Human Liver

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Drug Metabolism And Disposition

• Publication date

  2007-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.107.017269PMID 17670842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gemfibrozil

  2012influential reference
• Predominant Contribution of UDP-Glucuronosyltransferase 2B7 in the Glucuronidation of Racemic Flurbiprofen in the Human Liver

  2007cited by this paper
• Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid

  2007cited by this paper
• Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes

  2007cited by this paper
• GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

  2006cited by this paper
• In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.

  2006cited by this paper
• Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.

  2006cited by this paper
• Effect of gemfibrozil on the pharmacokinetics of pioglitazone

  2005cited by this paper
• UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES

  2005influential reference
• METABOLISM OF 26,26,26,27,27,27-F6-1α,23S,25-TRIHYDROXYVITAMIN D3 BY HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A3*

  2005cited by this paper
• Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil

  2004cited by this paper
• Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.

  2004cited by this paper
• Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients

  2003cited by this paper
• N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases.

  2003cited by this paper
• Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.

  2003influential reference
• Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

  2003cited by this paper
• Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients

  2003cited by this paper
• Mechanistic studies on metabolic interactions between gemfibrozil and statins.

  2002cited by this paper
• Effects of fibrates on metabolism of statins in human hepatocytes.

  2002cited by this paper
• Gemfibrozil greatly increases plasma concentrations of cerivastatin

  2002cited by this paper
• Glucuronidation in Humans

  1999cited by this paper
• Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells.

  1999cited by this paper
• Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.

  1997cited by this paper
• cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3.

  1996cited by this paper
• Simultaneous determination of gemfibrozil and its metabolites in plasma and urine by a fully automated high performance liquid chromatographic system.

  1991cited by this paper
• Pentoxifylline

  1987cited by this paper

• Male Hormonal Contraception—Current Stage of Knowledge

  2025cites this paper
• Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models

  2025cites this paper
• Contribution of Japanese scientists to drug metabolism and disposition.

  2025cites this paper
• The antihyperlipidemic effects of coenzyme Q10 and gemfibrozil on hyperlipidemic male rats: a comparative study

  2024cites this paper
• Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs

  2024cites this paper
• Analysis of in vitro and in vivo metabolism of zidovudine and gemfibrozil in trans‐chromosomic mouse line expressing human UGT2 enzymes

  2022cites this paper
• Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges

  2022cites this paper
• Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine

  2021cites this paper
• Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

  2021cites this paper
• Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.

  2020cites this paper
• The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.

  2019cites this paper
• Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism

  2019cites this paper
• Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes

  2019cites this paper
• Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8

  2019cites this paper
• Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry

  2018cites this paper
• Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate

  2018influential citation
• Characterization of oxycodone in vitro metabolism by human cytochromes P 450 and UDP-glucuronosyltransferases ROMAND

  2018cites this paper
• Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review

  2018cites this paper
• Toxicological potential of acyl glucuronides and its assessment.

  2017cites this paper
• Species‐related exposure of phase II metabolite gemfibrozil 1‐O‐β‐glucuronide between human and mice: A net induction of mouse P450 activity was revealed

  2017cites this paper
• Identification of Uridine 5′-Diphosphate-Glucuronosyltransferases Responsible for the Glucuronidation of Mirabegron, a Potent and Selective β3-Adrenoceptor Agonist, in Human Liver Microsomes

  2017cites this paper
• Glucuronides as Potential Anionic Substrates of Human Cytochrome P450 2C8 (CYP2C8).

  2017cites this paper
• Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters

  2017cites this paper
• Quantitative Analysis of Complex Drug-Drug Interactions Between Repaglinide and Cyclosporin A/Gemfibrozil Using Physiologically Based Pharmacokinetic Models With In Vitro Transporter/Enzyme Inhibition Data.

  2017cites this paper
• Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP‐glucuronosyltransferases

  2017cites this paper
• Separation of substrates and closely related glucuronide metabolites using various chromatographic modes.

  2016cites this paper
• Assessment of pharmacokinetic drug‐drug interaction between pradigastat and atazanavir or probenecid

  2016cites this paper
• Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions

  2016cites this paper
• Simultaneous analysis of gemfibrozil, morphine, and its two active metabolites in different mouse brain structures using solid-phase extraction with ultra-high performance liquid chromatography and tandem mass spectrometry with a deuterated internal standard.

  2016cites this paper
• Underlying mechanism of drug-drug interaction between pioglitazone and gemfibrozil: Gemfibrozil acyl-glucuronide is a mechanism-based inhibitor of CYP2C8.

  2015cites this paper
• Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.

  2015cites this paper
• A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.

  2015cites this paper
• Contribution of cytochrome P450 and UDT-glucuronosyltransferase to the metabolism of drugs containing carboxylic acid groups: risk assessment of acylglucuronides using human hepatocytes

  2014cites this paper
• Transcriptional regulation of human UDP-glucuronosyltransferase genes

  2014influential citation
• Role of CYP2C8 in the metabolism of montelukast and imatinib : Studies in vitro, in silico and in humans

  2014cites this paper
• LC-MS/MS Analysis of Pharmaceuticals in the Irish Aquatic Environment and the Potential for Human Exposure

  2014cites this paper
• Major Human Conjugative Drug‐Metabolizing Enzymes

  2014cites this paper
• Metabolism and Pharmacokinetics of Novel Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor Apatinib in Humans

  2013cites this paper
• Metabolism and Pharmacokinetics of Novel Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor Apatinib in Humans s

  2013cites this paper
• 2D QSAR Study for Gemfibrozil Glucuronide as the Mechanism-based Inhibitor of CYP2C8

  2013cites this paper
• The determination of pharmaceutical residues in cooked and uncooked marine bivalves using pressurised liquid extraction, solid-phase extraction and liquid chromatography–tandem mass spectrometry

  2013cites this paper
• Modulation of the UGT2B7 Enzyme Activity by C-Terminally Truncated Proteins Derived from Alternative Splicing

  2013cites this paper
• Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.

  2013cites this paper
• Transporter study methodologies

  2013cites this paper
• Proteins Derived from Alternative Splicing

  2013cites this paper
• Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights

  2013influential citation
• Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP‐Glucuronosyltransferase (UGT) 1A3 and 2B7

  2013cites this paper
• DMD053876 2197..2205

  2013cites this paper
• Modulation of the UGT 2 B 7 Enzyme Activity by C-Terminally Truncated Proteins Derived from Alternative Splicing s

  2013cites this paper
• Autoinhibition of CYP3A4 Leads to Important Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

  2013cites this paper
• Autoinhibition of CYP 3 A 4 Leads to Important Role of CYP 2 C 8 in Imatinib Metabolism : Variability in CYP 2 C 8 Activity May Alter Plasma Concentrations and Response s

  2012cites this paper
• Characterization of In Vitro Glucuronidation Clearance of a Range of Drugs in Human Kidney Microsomes: Comparison with Liver and Intestinal Glucuronidation and Impact of Albumin

  2012cites this paper
• Human UDP-Glucuronosyltransferase Isoforms Involved in Haloperidol Glucuronidation and Quantitative Estimation of Their Contribution

  2012cites this paper
• Identification of Human UDP-Glucuronosyltransferases Involved in N-Carbamoyl Glucuronidation of Lorcaserin

  2012cites this paper
• Effect of Gemfibrozil on the Metabolism of Brivaracetam In Vitro and in Human Subjects

  2012cites this paper
• Identification of Human UDP-Glucuronosyltransferases Involved in N -Carbamoyl Glucuronidation of Lorcaserin

  2012cites this paper
• Autoinhibition of CYP3A4 Leads to Major Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

  2012influential citation
• Autoinhibition of CYP3A4 Leads to Major Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response

  2012cites this paper
• ADME of Cardiovascular Drugs

  2012cites this paper
• Clinical applicability of sequence variations in genes related to drug metabolism.

  2011cites this paper
• Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes

  2011cites this paper
• Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution

  2011cites this paper
• Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution

  2011cites this paper
• Mechanism‐Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans

  2011cites this paper
• Mechanism-based inhibition of CYP2C8 by gemfibrozil in humans : characterisation of time and dose relationships

  2011cites this paper
• Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling.

  2011cites this paper
• The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

  2010cites this paper
• [Mechanisms of pharmacokinetic drug-drug interactions].

  2010cites this paper
• An Introduction to Metabolic Reaction Phenotyping

  2010cites this paper
• Mécanismes des interactions médicamenteuses d’origine pharmacocinétique

  2010cites this paper
• Relative Importance of Intestinal and Hepatic Glucuronidation—Impact on the Prediction of Drug Clearance

  2009cites this paper
• Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

  2009cites this paper
• Benzylic oxidation of gemfibrozil-1-O-beta-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition.

  2009cites this paper
• Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir

  2009cites this paper
• Myopathy with statin–fibrate combination therapy: clinical considerations

  2009cites this paper
• UDP-Glucuronosyltransferase 1A6 Is the Major Isozyme Responsible for Protocatechuic Aldehyde Glucuronidation in Human Liver Microsomes

  2008cites this paper
• STUDIES ON CYP 2 C 8-MEDIATED DRUG INTERACTIONS

  2008cites this paper
• The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984–2008

  2008cites this paper
• Clinical pharmacogenetics and potential application in personalized medicine.

  2008cites this paper
• Gemfibrozil Glucuronidation in Human Liver Microsomes is Catalyzed by UDP

  2008cites this paper
• STUDIES ON CYP2C8-MEDIATED DRUG INTERACTIONS

  2008cites this paper